This week in Orthopaedic Oncology

Jun 22–28, 2026 · 20 new studies, 6 reviews · Orthopaedic Oncology archive · All weeks

The new Orthopaedic Oncology research The Reduction sent the week of Jun 22–28, 2026, with the week’s most recent reviews, each with a one-line summary.

Get papers like these by email, free: subscribe to The Reduction, focused on your interests, on the days you pick.

New research

  1. Tumour-to-tumour metastasis: head and neck squamous cell carcinoma to enchondroma.

    Skeletal Radiology · Sep 2026 · PubMed

    Tumor-to-tumor metastasis of head and neck squamous cell carcinoma to benign enchondroma is exceptionally rare, representing an unusual malignancy pattern.

  2. Differentiating Schmorl's nodes from osteolytic bone metastases: diagnostic performance of conventional CT features and CT-based models incorporating radiomics and CT features.

    Skeletal Radiology · Sep 2026 · PubMed

    CT features of sclerotic margin distribution and thickness reliably differentiate Schmorl's nodes from osteolytic metastases without radiomics enhancement.

  3. Intramedullary Reaming Biopsy in Diagnosing Metastatic Long Bone Disease.

    Journal of Orthopaedic Trauma · Sep 01 2026 · PubMed

    Intramedullary reaming biopsy has 70% sensitivity for diagnosing metastatic disease in long bone lesions; formal open biopsy should be considered for negative results.

  4. Orthoplastic Surgery: A Practical Approach to Limb Salvage.

    Journal of the American Academy of Orthopaedic Surgeons · Sep 01 2026 · PubMed

    Orthoplastic protocols combining orthopedic and plastic surgical principles reduce time to fixation and coverage, decreasing infection risk and improving limb salvage outcomes.

  5. Recurrence of Giant Cell Tumor of Bone and Related Risk Factors: A Retrospective Analysis of 340 Cases From a Single Center.

    Journal of Surgical Oncology · Aug 2026 · PubMed

    Scaphoid fracture surgical fixation in elderly patients achieves high union rates comparable to younger cohorts, supporting operative management in appropriate candidates.

  6. Carbon fiber-reinforced peek versus titanium implants for the surgical treatment of spinal metastases: Evaluation of local disease control and quality of life.

    Journal of Bone Oncology · Aug 2026 · PubMed

    Carbon fiber-reinforced PEEK and titanium spinal implants show comparable survival and local disease control in vertebral metastases treatment.

  7. Effect of Timing of First Consultation with a Sarcoma Specialist Following Unplanned Excision: Oncologic Outcomes of Patients with Soft-Tissue Sarcomas.

    Journal of Bone and Joint Surgery (American) · Aug 19 2026 · PubMed

    Delayed referral to a sarcoma center after unplanned soft-tissue sarcoma excision is independently associated with significantly higher metastasis rates and mortality, emphasizing urgent specialist referral.

  8. Understanding Physical Functioning in Patients with Sarcoma After Amputation: Using an International Classification of Functioning, Disability and Health (ICF) Approach.

    Annals of Surgical Oncology · Jul 2026 · PubMed

    Common quality-of-life measures underestimate physical functioning burden in sarcoma patients post-amputation; ICF framework highlights overlooked domains.

  9. Consensus Guidelines on Perioperative Care in Primary Retroperitoneal Sarcoma Surgery.

    Annals of Surgical Oncology · Jul 2026 · PubMed

    First consensus perioperative guidelines for primary retroperitoneal sarcoma surgery provide multidisciplinary ERAS-based recommendations to standardize care and improve outcomes in this high-risk population.

  10. Evaluation of Language Diversity Among Orthopaedic Surgeons.

    Journal of the American Academy of Orthopaedic Surgeons · Jul 01 2026 · PubMed

    Only 8.3% of orthopaedic surgeons speak languages beyond English, creating significant disparities with patient populations and limiting language-concordant care.

  11. Recombinant LGR4 extracellular domain attenuates osteoclastogenesis and prevents bone metastasis via RANKL inhibition.

    Journal of Bone Oncology · Jun 2026 · PubMed

    Recombinant LGR4 extracellular domain inhibits osteoclast formation and reduces bone metastasis burden by 67%, suggesting novel therapeutic potential.

  12. Nationwide epidemiologic study of osteochondroma in Japan: Analysis of 4843 cases from the bone and soft tissue tumor registry.

    Journal of Bone Oncology · Jun 2026 · PubMed

    Osteochondroma in Japan (4,843 cases) most commonly affects ages under 20 in the lower limb; multiple osteochondroma presents younger with symmetric distribution.

  13. Development and validation of a biopsy-based model using tumor-associated neutrophils to predict neoadjuvant chemotherapy response in osteosarcoma: a large single-center retrospective cohort study.

    Journal of Bone Oncology · Jun 2026 · PubMed

    Higher tumor-associated neutrophil density predicts poor neoadjuvant chemotherapy response in osteosarcoma; biopsy-based model enables early risk stratification.

  14. Safety of Pre-Operative Radiotherapy Combined With Intraoperative Radiotherapy for Retroperitoneal Sarcoma.

    Journal of Surgical Oncology · Jun 2026 · PubMed

    Neoadjuvant EBRT with intraoperative IORT for retroperitoneal sarcoma carries 25% major complication rate, similar to EBRT alone with acceptable morbidity profile.

  15. Age-related real-world treatment patterns and outcomes of localised, high-grade osteosarcoma.

    Journal of Bone Oncology · Jun 2026 · PubMed

    Wide resection plus perioperative chemotherapy improves osteosarcoma survival at all ages; for patients over 40, guideline-concordant treatment remains the standard regardless of chemotherapy sequencing.

  16. Dual-target neoadjuvant therapy with denosumab and sunitinib for giant cell tumor of bone: a sarcoma center experience.

    Journal of Bone Oncology · Jun 2026 · PubMed

    Neoadjuvant denosumab plus sunitinib for high-grade giant cell tumor of bone produced near-complete giant cell regression and 80% two-year disease-free survival, supporting further prospective study of this dual-targeted approach.

  17. Dorsal spinal instrumentation in multiple myeloma: postoperative acute kidney injury is associated with mortality, morbidity, and deterioration of bone and muscle status.

    European Spine Journal · Jun 23 2026 · PubMed

    Postoperative acute kidney injury in myeloma patients undergoing spinal surgery independently worsens survival, increases infection risk, and accelerates muscle and bone loss.

  18. Posterolateral approach for lumbar plexus intra-psoas schwannomas: systematic review and comparative anthropometric analysis of surgical corridors with an illustrative case.

    European Spine Journal · Jun 15 2026 · PubMed

    Posterolateral Wiltse-type corridor provides short surgical trajectory with good instrument maneuverability for intra-psoas schwannomas as alternative to anterior approaches.

  19. Implant survival and limb salvage rates after combined proximal tibial and distal femoral endoprosthetic replacement.

    The Bone & Joint Journal · Jun 01 2026 · PubMed

    Composite endoprosthetic reconstruction around the knee achieves 61% ten-year implant survival with acceptable functional outcomes; infection is leading cause of late failure.

  20. Impact of complications on survival after surgery for metastatic spinal cord compression.

    European Spine Journal · Jun 01 2026 · PubMed

    Postoperative systemic complications independently reduce survival after metastatic spinal cord compression surgery; impaired preoperative ambulation predicts higher complication risk and should guide surgical decision-making.

Recent reviews

  1. Decoding the immune landscape in Ewing sarcoma pathogenesis: The role of tumor infiltrating immune cells and immune milieu.

    Journal of Bone Oncology · Jun 2025 · PubMed

    Ewing sarcoma tumor microenvironment includes immunosuppressive cells and molecules impairing anti-tumor immunity; targeting these offers therapeutic potential.

  2. Diagnostic errors in musculoskeletal oncology and possible mitigation strategies.

    Skeletal Radiology · Mar 2023 · PubMed

    Cognitive biases—especially anchoring, premature closure, and availability bias—are the primary drivers of diagnostic error in musculoskeletal oncology imaging and can be mitigated through structured reasoning.

  3. State-of-the-art of minimally invasive treatments of bone metastases.

    Journal of Bone Oncology · Jun 2022 · PubMed

    Minimally invasive interventional procedures treat bone metastases with less trauma than open surgery; advances in technology expand treatment options beyond conservative care.

  4. Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approval.

    Journal of Bone Oncology · Apr 2022 · PubMed

    Denosumab effectively prevents skeletal-related events in metastatic bone disease but requires monitoring for rare serious toxicities including osteonecrosis of jaw.

  5. Telangiectatic soft tissue sarcoma and chronic expanding haematoma: a comparative review of MRI features.

    Skeletal Radiology · Dec 2021 · PubMed

    Telangiectatic soft tissue sarcomas with dominant hemorrhage can mimic benign chronic expanding hematomas; any lesion with sizeable hemorrhage warrants referral to sarcoma center.

  6. Sarcoma Surveillance: A Review of Current Evidence and Guidelines.

    Journal of the American Academy of Orthopaedic Surgeons · Feb 15 2020 · PubMed

    No universal sarcoma surveillance standards exist; follow-up should be intense early post-treatment, continue 10 years, with modality selection individualized by type.

← Week of Jun 15–21, 2026Week of Jun 29 – Jul 5, 2026 →

Home  ·  All weeks  ·  Archive  ·  Subscribe  ·  FAQ

© 2026 The Reduction